Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications

Diabetes mellitus is the major risk factor for the development of macrovascular and microvascular complications. It is increasingly recognized that glycemic variability (GV), referring to oscillations in blood glucose levels and representing either short-term or long-term GV, is involved in the pathogenesis of diabetic complications and has emerged as a possible independent risk factor for them. In this review, we summarize the metrics and measurement of GV in clinical practice, as well as comprehensively elaborate the role and related mechanisms of GV in diabetic macrovascular and microvascular complications, aiming to provide the mechanism-based therapeutic strategies for clinicians to manage diabetes mellitus.

Automated summary

Glycemic variability (GV) is recognized as a possible independent risk factor for diabetic complications, with this review summarizing the metrics and measurement of GV in clinical practice and elaborating its role and related mechanisms in both macrovascular and microvascular complications of diabetes to provide mechanism-based therapeutic strategies for clinicians.